Discussion - session II

Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

Number: 10

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Discussion - session II. Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Discussion - session III Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009
Discussion - session I Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009
Discussion and Q/A Source: Virtual Congress 2020 – Physiology Year: 2020
Discussion and Q&A Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021
Discussion and Q&A Source: Virtual Congress 2021 – Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease? Year: 2021
Discussion Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021
Discussion and Q&A Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment Year: 2021